US FDA Denies Emergency Use Approval to Bharat Biotech's Covaxin

This article has been removed following an ex parte injunction of a court in Telangana, delivered following a petition filed by Bharat Biotech Ltd.

Jun 11 2021

This article has been removed following an ex parte injunction of a court in Telangana, delivered following a petition filed by Bharat Biotech Ltd.

A photograph tweeted by S. Jaishankar, showing Covaxin being sent to Paraguay. Photo: Twitter/@DrSJaishankar

This article has been removed following an ex parte injunction of a court in Telangana, delivered following a petition filed by Bharat Biotech Ltd.

Bharat Biotech has also filed a Rs 100 crore defamation case against The Wire, its editors, and 10 staffers and contributors.

The Wire will be fighting this injunction and defamation plaint.

This article went live on June eleventh, two thousand twenty one, at twenty-nine minutes past twelve at noon.

The Wire is now on WhatsApp. Follow our channel for sharp analysis and opinions on the latest developments.

Make a contribution to Independent Journalism

Real journalism holds power accountable